The impact of renal function on the long-term clinical course of patients who underwent percutaneous coronary

Related Experiment Videos

Insights

Reduced kidney function significantly increases long-term mortality after percutaneous coronary intervention (PCI). Even mild chronic kidney disease (CKD) poses a higher risk for cardiac and all-cause death post-PCI.

Area of Science:

  • Cardiology
  • Nephrology
  • Clinical Medicine

Background:

  • Chronic kidney disease (CKD) is linked to higher mortality after percutaneous coronary intervention (PCI).
  • Understanding long-term outcomes in CKD patients undergoing PCI is crucial for risk stratification.

Purpose of the Study:

  • To assess the impact of varying kidney function levels on long-term clinical outcomes after successful PCI.
  • To investigate the relationship between glomerular filtration rate (GFR) and major adverse cardiac events (MACE) beyond 5 years.

Main Methods:

  • Retrospective analysis of 371 non-dialysis patients undergoing successful PCI.
  • Stratification based on baseline estimated glomerular filtration rate (eGFR): normal/mildly impaired (≥60 ml/min/1.73 m²) vs. CKD (<60 ml/min/1.73 m²).
  • Multivariate Cox regression analysis to determine the independent effect of eGFR on long-term mortality and MACE.

Main Results:

  • Nine-year all-cause and cardiac mortality were substantially higher in the CKD group (45.9% vs. 10.6% and 35.4% vs. 7.1%, respectively; P < 0.0001).
  • No significant differences were observed in repeat revascularization or nonfatal myocardial infarction rates.
  • Multivariate analysis confirmed that lower eGFR independently predicts increased long-term all-cause and cardiac mortality.

Conclusions:

  • Kidney function level is a critical determinant of long-term mortality following successful PCI.
  • Even mild reductions in GFR are associated with significantly worse long-term survival after PCI.
Abstract

Related Concept Videos

Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
Factors Affecting Renal Clearance: Renal Impairment01:17

Factors Affecting Renal Clearance: Renal Impairment

Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
Renal Failure: Dose Adjustments01:11

Renal Failure: Dose Adjustments

In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant01:25

Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant

In patients with renal disease, dosage adjustments are necessary to maintain therapeutic plasma drug concentrations and prevent toxicity or subtherapeutic exposure. Renal impairment alters drug pharmacokinetics, especially in conditions like uremia, where changes such as prolonged elimination half-life and altered apparent volume of distribution can significantly affect drug disposition. These changes require careful modification of the dosing regimen to achieve the desired clinical...